logo
Share SHARE
FONT-SIZE Plus   Neg

Life Technologies Showcases Leading Technologies For Cancer Research At AACR

Life Technologies Corp. (LIFE) said it will exhibit products across the spectrum of basic, translational and clinical cancer research during the American Association of Cancer Research or AACR Annual Meeting 2012, taking place March 31 - April 4, in Chicago, Illinois.

Presentations included in this exhibition are triple negative breast cancer, Semiconductor sequencing of melanoma samples, the company said.

Triple negative breast tumors, which make up nearly 20 percent of breast cancers, do not respond to treatment with targeted therapies such as Herceptin. To investigate new options for these patients, the first clinical trial of whole-genome sequencing for women with triple negative breast cancer was initiated in March 2010; early results will be presented by John Carpten, head of the Integrated Cancer Genomics Division at the Phoenix-based Translational Genomics Research Institute or Tgen.

In addition, George Watts, research assistant professor and co-director of the Genomics Shared Service at The University of Arizona Cancer Center, will present a poster demonstrating accurate, cost-effective sequencing of six commonly mutated genes in archived research samples from metastatic melanoma patients using the Life Technologies Ion Personal Genome Machine system.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Cable-cutters have now one more reason to do so as live television streaming will be available on YouTube TV in 14 more markets in the U.S. Facebook Chief Operating Officer Sheryl Sandberg has donated nearly $100 million in Facebook shares to charity. This is her second charitable donation within a year. A document was filed on Thursday with the Security and Exchange Commission, which shows that Sandberg transferred shares to a special fund she uses for charitable donations. Ford Motor Co.'s new CEO Jim Hackett has taken a more cautious approach to the automaker's plans for rolling out autonomous vehicles. Ford is currently undertaking a 100-day review of its operations and Hackett indicated at delays to the company's plans to launch a fully-autonomous vehicle by 2021.
comments powered by Disqus
Follow RTT